Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.40 |
| ▸ | PPARA | Q07869 | 7/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.38 |
| ▸ | PTGES | O14684 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2280554 | 0.73 | SMN1; SMN2 (0.65) | PPARGPPARASMN1; SMN2PTGESALOX5 | |
| SCHEMBL8527020 | 0.73 | SMN1; SMN2 (0.60) | PPARGPPARASMN1; SMN2PTGESALOX5 | |
| SCHEMBL5509034 | 0.73 | PPARG (0.56) | PPARGPPARA | |
| SCHEMBL2276993 | 0.71 | PPARG (0.40) | PPARGPPARASMN1; SMN2PTGESALOX5 | |
| SCHEMBL4655017 | 0.71 | PPARG (0.54) | PPARGPPARASMN1; SMN2HCAR1PTGES | |
| SCHEMBL2849301 | 0.70 | VCAM1 (0.44) | HCAR1ALDH1A1L3MBTL1 | |
| SCHEMBL11588663 | 0.69 | PPARG (0.47) | PPARGPPARA | |
| Orcinol SCHEMBL2849303 | 0.68 | HCAR1 (0.52) | HCAR1ALDH1A1 | |
| SCHEMBL8521338 | 0.68 | PPARG (0.52) | PPARGPPARAFOLH1 | |
| SCHEMBL28969462 | 0.67 | CYP1A2 (0.54) | FOLH1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2150119-B1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX INC (US) | 2018-04-11 | — | — | EP | disclosed |
| US-9491966-B2 | Dihydroxybenzoate polymers and uses thereof | TYRX, INC. (US) | 2016-11-15 | — | — | US | disclosed |
| US-20100129417-A1 | Dihydroxybenzoate Polymers and Uses Thereof | MEDTRONIC, INC. | 2010-05-27 | — | — | US | disclosed |
| EP-2150119-A1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX PHARMA INC. (US) | 2010-02-10 | — | — | EP | disclosed |
| WO-2008137807-A1 | DIHYDROXYBENZOATE POLYMERS AND USES THEREOF | TYRX PHARMA, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100129417-A1 | Dihydroxybenzoate Polymers and Uses Thereof | DDT, QDPR, HPD | PPARG 1338/4885PPARA 483/4885SMN1; SMN2 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.